Literature DB >> 24982580

Clinical and morphologic findings in disseminated Scedosporium apiospermum infections in immunocompromised patients.

Molly M Campa-Thompson1, James A West1, Joseph M Guileyardo1, Cedric W Spak1, Louis M Sloan1, Stacy G Beal1.   

Abstract

Scedosporium apiospermum is a ubiquitous, saprophytic, filamentous mold that may cause localized, subcutaneous infections in immunocompetent hosts, but disseminated infection in severely immunocompromised patients. This mold is often highly resistant to multiple commonly used antifungal drugs. Even with treatment, there is a high mortality rate. We present two patients with fatal disseminated S. apiospermum infections after bone marrow and lung transplantation. This infection can be rapidly fatal, and survival may be improved by early recognition.

Entities:  

Year:  2014        PMID: 24982580      PMCID: PMC4059584          DOI: 10.1080/08998280.2014.11929129

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  10 in total

1.  The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.

Authors:  S Schwartz; A Reisman; P F Troke
Journal:  Infection       Date:  2011-04-22       Impact factor: 3.553

2.  Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.

Authors:  Shahid Husain; Patricia Muñoz; Graeme Forrest; Barbara D Alexander; Jyoti Somani; Kathleen Brennan; Marilyn M Wagener; Nina Singh
Journal:  Clin Infect Dis       Date:  2004-12-08       Impact factor: 9.079

3.  Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.

Authors:  Kathrin Heyn; Antje Tredup; Stefanie Salvenmoser; Frank-Michael C Müller
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

4.  Cerebral scedosporiosis: an emerging fungal infection in severe neutropenic patients: CT features and CT pathologic correlation.

Authors:  Enrique Marco de Lucas; Pablo Sádaba; Pedro Lastra García-Barón; María Luisa Ruiz Delgado; Jorge Cuevas; Ricardo Salesa; Arancha Bermúdez; Andrés González Mandly; Agustín Gutiérrez; Fidel Fernández; Fernando Marco de Lucas; Consuelo Díez
Journal:  Eur Radiol       Date:  2005-08-20       Impact factor: 5.315

5.  Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.

Authors:  Michaela Lackner; G Sybren de Hoog; Paul E Verweij; Mohammad J Najafzadeh; Ilse Curfs-Breuker; Corné H Klaassen; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

6.  Disseminated Scedosporium apiospermum infection in a previously healthy woman with HELLP syndrome.

Authors:  J Riddell; C E Chenoweth; C A Kauffman
Journal:  Mycoses       Date:  2004-10       Impact factor: 4.377

Review 7.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 8.  Emerging fungal infections in solid organ transplant recipients.

Authors:  Shmuel Shoham
Journal:  Infect Dis Clin North Am       Date:  2013-04-17       Impact factor: 5.982

9.  Successful prevention of scedosporiosis after lung transplantation in a cystic fibrosis patient by combined local and systemic triazole therapy.

Authors:  Carolin Hartmann; Carsten Müller; Hartmut Weißbrodt; Sebastian Suerbaum; Kathrin Tintelnot; Stefan Stolle; Gesine Hansen; Ludwig Sedlacek
Journal:  Med Mycol Case Rep       Date:  2013-05-23

10.  ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.

Authors:  A M Tortorano; M Richardson; E Roilides; A van Diepeningen; M Caira; P Munoz; E Johnson; J Meletiadis; Z-D Pana; M Lackner; P Verweij; T Freiberger; O A Cornely; S Arikan-Akdagli; E Dannaoui; A H Groll; K Lagrou; A Chakrabarti; F Lanternier; L Pagano; A Skiada; M Akova; M C Arendrup; T Boekhout; A Chowdhary; M Cuenca-Estrella; J Guinea; J Guarro; S de Hoog; W Hope; S Kathuria; O Lortholary; J F Meis; A J Ullmann; G Petrikkos; C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2014-04       Impact factor: 8.067

  10 in total
  3 in total

Review 1.  Scedosporium apiospermum infection of the urinary system with a review of treatment options and cases in the literature.

Authors:  Esther Benamu; Alexander Tin-Han Yu; Lijia Xie; Sebastian Fernandez-Pol; Anne Y Liu; Dora Y Ho
Journal:  Transpl Infect Dis       Date:  2017-12-21       Impact factor: 2.228

2.  Skull base osteomyelitis secondary to Scedosporium apiospermum infection.

Authors:  Martin Doss; David Doss
Journal:  Radiol Case Rep       Date:  2018-06-06

3.  Scedosporium apiospermum as a rare cause of central skull base osteomyelitis.

Authors:  Päivi Jalava-Karvinen; Mikko Nyman; Maria Gardberg; Inka Harju; Ulla Hohenthal; Jarmo Oksi
Journal:  Med Mycol Case Rep       Date:  2016-04-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.